We are live on ! Find out more
SCA

Sassicaia Capital Advisers Portfolio holdings

AUM $88.8M
1-Year Est. Return 146.47%
This Fund
S&P 500
This Quarter Est. Return
+116.43%
1 Year Est. Return
+146.47%
3 Year Est. Return
+1,930.21%
5 Year Est. Return
+4,169.37%
10 Year Est. Return
AUM
$2.13M
AUM Growth
-$115M
Cap. Flow
-$116M
Cap. Flow %
-5,481.03%
Top 10 Hldgs %
100%
Holding
34
New
3
Increased
Reduced
2
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$265K
2
SLNO
Soleno Therapeutics
SLNO
+$52.4K
3
FEMY icon
Femasys
FEMY
+$37.6K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
NVDA icon
NVIDIA
NVDA
+$29.3M
3
NFLX icon
Netflix
NFLX
+$7.03M
4
TSLA icon
Tesla
TSLA
+$5.4M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$5.08M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 51.87%
2 Healthcare 33.81%
3 Technology 14.33%
4 Communication Services 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIVN icon
26
Rivian
RIVN
$23.7B
-57,900
Closed -$965K
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$807B
-4,850
Closed -$2.15M
UAL icon
28
United Airlines
UAL
$41B
-12,200
Closed -$669K
UBER icon
29
Uber
UBER
$160B
-10,140
Closed -$438K
WH icon
30
Wyndham Hotels & Resorts
WH
$5.38B
-18,001
Closed -$1.23M
XFOR icon
31
X4 Pharmaceuticals
XFOR
$424M
-4,600
Closed -$268K
XPEV icon
32
XPeng
XPEV
$11.4B
-12,000
Closed -$161K
FNGA
33
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
-15,820
Closed -$2.96M
ENFN
34
DELISTED
Enfusion, Inc.
ENFN
-22,000
Closed -$247K

Similar funds

Sassicaia Capital Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Sassicaia Capital Advisers held 34 positions worth $2.13M, down 98% from $117M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sassicaia Capital Advisers withdrew a net $116M in Q3 2023, closing 28 positions and reducing 2 holdings. Its most notable exit was Apple, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 52% of assets, up from 9% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Sassicaia Capital Advisers opened a new position in Pfizer worth $249K.

  • Sassicaia Capital Advisers's largest Q3 2023 buy was Pfizer: 7,500 shares worth $249K.
  • Sassicaia Capital Advisers's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $29.3M.
  • Sassicaia Capital Advisers fully exited Apple in Q3 2023, selling an estimated $46.2M.
  • Sassicaia Capital Advisers's ten largest holdings make up 100% of its $2.13M portfolio in Q3 2023.
  • Sassicaia Capital Advisers opened 3 new positions and closed 28 in Q3 2023.
  • Sassicaia Capital Advisers's portfolio value fell 98% quarter-over-quarter to $2.13M.

Based on Sassicaia Capital Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.